Literature DB >> 23295476

Exploring the cross-reactivity of S25-2: complex with a 5,6-dehydro-Kdo disaccharide.

Cory L Brooks1, Kurt Wimmer, Paul Kosma, Sven Müller-Loennies, Lore Brade, Helmut Brade, Stephen V Evans.   

Abstract

The near-germline antibody S25-2 exhibits a remarkable cross-reactivity for oligosaccharides containing the bacterial lipopolysaccharide carbohydrate 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo). The recent synthesis of a variety of Kdo analogues permits a detailed structural analysis of the importance of specific interactions in antigen recognition by S25-2. The Kdo disaccharide analogue Kdo-(2→4)-5,6-dehydro-Kdo lacks a 5-OH group on the second Kdo residue and has been cocrystallized with S25-2. The structure reveals that the modification of the Kdo residue at position 5 results in a rearrangement of intramolecular hydrogen bonds in the antigen that allows it to assume a novel conformation in the antibody-combining site. The cross-reactive binding of S25-2 to this synthetic ligand highlights the adaptability of this antibody to non-natural synthetic analogues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23295476      PMCID: PMC3539693          DOI: 10.1107/S1744309112047422

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  16 in total

1.  Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site.

Authors:  V Manivel; N C Sahoo; D M Salunke; K V Rao
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

2.  NMR experiments reveal distinct antibody-bound conformations of a synthetic disaccharide representing a general structural element of bacterial lipopolysaccharide epitopes.

Authors:  T Haselhorst; J F Espinosa; J Jiménez-Barbero; T Sokolowski; P Kosma; H Brade; L Brade; T Peters
Journal:  Biochemistry       Date:  1999-05-18       Impact factor: 3.162

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  Intraclonal generation of antibody mutants in germinal centres.

Authors:  J Jacob; G Kelsoe; K Rajewsky; U Weiss
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

5.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

6.  Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions.

Authors:  N Hozumi; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

7.  Synthesis and antigenic properties of C-7-modified Kdo mono- and disaccharide ligands and Kdo disaccharide interresidue lactones.

Authors:  Georg Sixta; Kurt Wimmer; Andreas Hofinger; Helmut Brade; Paul Kosma
Journal:  Carbohydr Res       Date:  2009-06-21       Impact factor: 2.104

8.  Structural insights into parallel strategies for germline antibody recognition of lipopolysaccharide from Chlamydia.

Authors:  Dylan W Evans; Sven Müller-Loennies; Cory L Brooks; Lore Brade; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  Glycobiology       Date:  2011-05-04       Impact factor: 4.313

9.  Exploration of specificity in germline monoclonal antibody recognition of a range of natural and synthetic epitopes.

Authors:  Cory L Brooks; Sven Müller-Loennies; Lore Brade; Paul Kosma; Tomoko Hirama; C Roger MacKenzie; Helmut Brade; Stephen V Evans
Journal:  J Mol Biol       Date:  2008-01-16       Impact factor: 5.469

10.  A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart.

Authors:  Y Fu; M Baumann; P Kosma; L Brade; H Brade
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more
  3 in total

1.  Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Radka Saldova; Mohankumar Muniyappa; Lore Brade; Pauline M Rudd; David J Harvey; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2014-03-28       Impact factor: 5.157

2.  Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose.

Authors:  Robyn L Stanfield; Cristina De Castro; Alberto M Marzaioli; Ian A Wilson; Ralph Pantophlet
Journal:  Glycobiology       Date:  2014-11-07       Impact factor: 4.313

3.  Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.

Authors:  Mohammadreza Movahedin; Teresa M Brooks; Nitin T Supekar; Naveen Gokanapudi; Geert-Jan Boons; Cory L Brooks
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.